首页/数据集/Transcription profiling of human tumor cell line TPC-1 treated with siRNAs targetting RET mRNA and the RET/PTC1 junction

Transcription profiling of human tumor cell line TPC-1 treated with siRNAs targetting RET mRNA and the RET/PTC1 junction

ChEBI2010-05-01 更新2026-07-21 收录

癌症基因融合研究

RNA干扰治疗

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-TABM-746 数据链接链接失效反馈

官方服务：

资源简介：

Transcription profiling of human tumor cell line TPC-1 treated with siRNAs targetting RET mRNA and the RET/PTC1 junction

应用场景：

创建时间：

2010-05-01

RNA干扰治疗

癌细胞机制

>80% of a large number of tested siRNAs and shRNAs targeting CD95 or CD95 ligand (CD95L) induce a form of cell death that is characterized by the simultaneous activation of multiple death pathways and

NIAID Data Ecosystem60

CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL1.RNAseq.lg]

RNA干扰治疗

癌症基因靶向

We provide evidence that shRNAs and siRNAs derived from CD95 and CD95L preferentially target the 3' UTRs of survival genes culminating in a very robust mode of cell death we call DISE (Death Induced b

NIAID Data Ecosystem30

Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells. Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells

RNA干扰治疗

三核苷酸重复siRNA毒性

Triplet repeat siRNAs as found amplified in diseases such as Huntingtons disease can be used to kill cancer cells Overall design: RNA isolated from HeyA8 cells 48 hrs after transfection with either a

NIAID Data Ecosystem30

Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids

先天性病毒感染

RNA干扰治疗

The re-emergence of Zika virus (ZIKV) in the Western Hemisphere has resulted in global public health crisis since 2015. ZIKV preferentially infects and targets human neural progenitor cells (hNPCs) an

NIAID Data Ecosystem50

Supplementary Material for: Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication

HCV基因治疗

RNA干扰治疗

Background: The RNAi-based transient therapeutic approach has been well explored for its potential against the hepatitis V virus (HCV). However, to achieve a sustained virological response, a consiste

Figshare2018-09-25 更新30

Transcription profiling of human tumor cell line TPC-1 treated with siRNAs targetting RET mRNA and the RET/PTC1 junction

资源简介：

相关数据集